This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boerlin, P.
Right arrow Articles by Nicolet, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boerlin, P.
Right arrow Articles by Nicolet, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2001, p. 4193-4195, Vol. 39, No. 11
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.11.4193-4195.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Antimicrobial Growth Promoter Ban and Resistance to Macrolides and Vancomycin in Enterococci from Pigs

P. Boerlin,1,* A. Wissing,1 F. M. Aarestrup,2 J. Frey,1 and J. Nicolet1

Institute for Veterinary Bacteriology, University of Bern, Bern, Switzerland,1 and Danish Veterinary Laboratory, Copenhagen, Denmark2

Received 30 November 2001/Returned for modification 29 March 2001/Accepted 3 September 2001

Ninety-six enterococcus isolates from fecal samples of pigs receiving tylosin as an antimicrobial growth promoter and 59 isolates obtained in the same farms 5 to 6 months after the ban of antimicrobial growth promoters in Switzerland were tested for susceptibility to nine antimicrobial agents. A clear decrease in resistance to macrolides, lincosamides, and tetracycline was visible after the ban. Vancomycin-resistant Enterococcus faecium belonged to the same clonal lineage as vancomycin-resistant isolates previously isolated from Danish pigs.


* Corresponding author. Mailing address: Institute for Veterinary Bacteriology, Länggass-Strasse 122, 3012 Bern, Switzerland. Phone: (41) 31 631 2368. Fax: (41) 31 631 2634. E-mail: patrick.boerlin{at}vbi.unibe.ch.


Journal of Clinical Microbiology, November 2001, p. 4193-4195, Vol. 39, No. 11
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.11.4193-4195.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bustamante, W., Alpizar, A., Hernandez, S., Pacheco, A., Vargas, N., Herrera, M. L., Vargas, A., Caballero, M., Garcia, F. (2003). Predominance of vanA Genotype among Vancomycin-Resistant Enterococcus Isolates from Poultry and Swine in Costa Rica. Appl. Environ. Microbiol. 69: 7414-7419 [Abstract] [Full Text]  
  • Rice, L. B. (2003). Collateral Damage. ANN INTERN MED 139: 523-524 [Full Text]  
  • Manson, J. M., Keis, S., Smith, J. M. B., Cook, G. M. (2003). A Clonal Lineage of VanA-Type Enterococcus faecalis Predominates in Vancomycin-Resistant Enterococci Isolated in New Zealand. Antimicrob. Agents Chemother. 47: 204-210 [Abstract] [Full Text]